These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3509494)

  • 21. [Antibiotic binding to blood proteins and its significance in therapy].
    Chojnowski W; Gralewicz J
    Pol Tyg Lek; 1974 Jul; 29(28):1223-5. PubMed ID: 4603113
    [No Abstract]   [Full Text] [Related]  

  • 22. [Undecatungstophosphate sensitized strains of methicillin-resistant Staphylococcus aureus to beta-lactams].
    Tajima Y
    Rinsho Byori; 2002 Feb; 50(2):173-85. PubMed ID: 11925856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of beta-lactam antibiotics.
    Bergan T
    Scand J Infect Dis Suppl; 1984; 42():83-98. PubMed ID: 6597564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma protein binding of fluoroquinolones affects antimicrobial activity.
    Zeitlinger M; Sauermann R; Fille M; Hausdorfer J; Leitner I; Müller M
    J Antimicrob Chemother; 2008 Mar; 61(3):561-7. PubMed ID: 18216178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution and resistance expression of MRSA. Evaluation of beta-lactam antibiotics against a set of isogenic strains with different types of phenotypic expression.
    Asada K; Inaba Y; Tateda-Suzuki E; Kuwahara-Arai K; Ito T; Hiramatsu K
    Acta Biochim Pol; 1995; 42(4):517-24. PubMed ID: 8852342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitivity of methicillin-resistant Staphylococcus aureus (MRSA) to antimicrobial agents other than beta-lactams: profile and trend, 1998-2003.
    Manfredi R; Nanetti A; Morelli S; Valentini R; Calza L; Chiodo F
    Isr Med Assoc J; 2004 Mar; 6(3):191-2. PubMed ID: 15055283
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanisms of resistance to beta-lactam antibiotics.
    Wiedemann B; Tolxdorff-Neutzling RM
    Chemioterapia; 1985 Feb; 4(1):24-7. PubMed ID: 3986943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A proteolytic transmembrane signaling pathway and resistance to beta-lactams in staphylococci.
    Zhang HZ; Hackbarth CJ; Chansky KM; Chambers HF
    Science; 2001 Mar; 291(5510):1962-5. PubMed ID: 11239156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Resistance of hospital Staphylococci to beta-lactam antibiotics].
    Kukulianskiĭ AA; Suchshevich VV; Sokolovskaia AD; Rimzha MI
    Antibiot Khimioter; 1991 Sep; 36(9):9-11. PubMed ID: 1781719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Binding of sisomicin and gentamicin to serum proteins (author's transl)].
    Rosenkranz H; Scheer M; Scholtan W
    Arzneimittelforschung; 1976; 26(8):1517-21. PubMed ID: 1036948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of hydrogen ion and protein concentrations on the activity of beta-lactam antibiotics.
    Platt R; Rosner B
    Rev Infect Dis; 1984; 6 Suppl 4():S829-34. PubMed ID: 6522925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of human serum on inhibition of growth of Staphylococcus aureus by antimicrobial agents.
    Stratton CW; Evans ME; Burch DJ; Hawley HB; Horsman TA; Tu KK; Reller LB
    Eur J Clin Microbiol; 1986 Jun; 5(3):351-3. PubMed ID: 3743559
    [No Abstract]   [Full Text] [Related]  

  • 33. [Quantitative and qualitative aspects of the interaction of antibiotics and proteins. III. Comparative studies on the affinity of various selected cationic and anionic antibiotics to blood serum albumin].
    Chojnowski W; Gralewicz J; Lupicki W
    Acta Pol Pharm; 1978; 35(3):365-71. PubMed ID: 696371
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of antibiotic concentration on the killing of Staphylococcus aureus and Enterococcus faecalis: comparison of the novel penem, Men 10700, with other beta-lactam antibiotics.
    Hamilton-Miller JM; Shah S
    J Antimicrob Chemother; 1999 Sep; 44(3):418-20. PubMed ID: 10511416
    [No Abstract]   [Full Text] [Related]  

  • 35. Testing Staphylococcus aureus for resistance to beta-lactams.
    Goldstein FW; Acar J
    J Antimicrob Chemother; 1991 Apr; 27(4):549-50. PubMed ID: 1953884
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antibiotics and protein binding].
    Tillement JP; Chauvelot L
    Therapie; 1978; 33(3):235-49. PubMed ID: 356336
    [No Abstract]   [Full Text] [Related]  

  • 37. Interaction of beta-lactam antibiotics on bilirubin-albumin complex: comparison by three methods, total bilirubin, unbound bilirubin and erythrocyte-bound bilirubin.
    Gulian JM; Dalmasso C; Gonard V
    Chemotherapy; 1990; 36(2):91-7. PubMed ID: 2311445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of protein binding on antibiotic activity in vivo.
    Merrikin DJ; Briant J; Rolinson GN
    J Antimicrob Chemother; 1983 Mar; 11(3):233-8. PubMed ID: 6841305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of human serum on pharmacodynamic properties of an investigational glycopeptide, LY333328, and comparator agents against Staphylococcus aureus.
    Zhanel GG; Kirkpatrick ID; Hoban DJ; Kabani AM; Karlowsky JA
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2427-30. PubMed ID: 9736576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analytical studies on beta-lactam antibiotics. II. Displacement effect of beta-lactam antibiotics on bilirubin bound to human serum albumin.
    Matsuura A; Nagayama T; Kitagawa T
    Chemotherapy; 1988; 34(4):345-53. PubMed ID: 3208550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.